2023
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial. (Journal article)
Flohr, C., Rosala-Hallas, A., Jones, A. P., Beattie, P., Baron, S., Browne, F., . . . TREAT Trial Investigators. (2023). Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial.. The British journal of dermatology, 189(6), 674-684. doi:10.1093/bjd/ljad281DOI: 10.1093/bjd/ljad281
2022
Rosala-Hallas, A., Jones, A. P., Williamson, P. R., Bedson, E., Compton, V., Fernandes, R. M., . . . McNamara, P. S. (2022). Which outcomes should be used in future bronchiolitis trials? Developing a bronchiolitis core outcome set using a systematic review, Delphi survey and a consensus workshop. BMJ Open, 12(3), e052943. doi:10.1136/bmjopen-2021-052943DOI: 10.1136/bmjopen-2021-052943
McNamara, P. S., Clayton, D., Burchett, C., Compton, V., Peak, M., Clark, J., & Jones, A. P. (2022). Humidified and standard oxygen therapy in acute severe asthma in children (HUMOX): A pilot randomised controlled trial.. PloS one, 17(2), e0263044. doi:10.1371/journal.pone.0263044DOI: 10.1371/journal.pone.0263044
2021
Gale, C., Dorling, J., Arch, B., Woolfall, K., Deja, E., Roper, L., . . . Tume, L. (2021). Optimal outcome measures for a trial of not routinely measuring gastric residual volume in neonatal care: a mixed methods consensus process. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 106(3), F292-F297. doi:10.1136/archdischild-2020-319469DOI: 10.1136/archdischild-2020-319469
Setiabudi, W., Hungerford, D., Subramaniam, K., Vaselli, N. M., Shaw, V. E., Wilton, M., . . . French, N. (2021). Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol. BMJ Open, 11(3), e048317. doi:10.1136/bmjopen-2020-048317DOI: 10.1136/bmjopen-2020-048317
McKay, A. J., Jones, A. P., Gamble, C. L., Farmer, A. J., & Williamson, P. R. (n.d.). Use of routinely collected data in a UK cohort of publicly funded randomised clinical trials. F1000Research, 9, 323. doi:10.12688/f1000research.23316.3DOI: 10.12688/f1000research.23316.3
Tume, L. N., Arch, B., Woolfall, K., Roper, L., Deja, E., Jones, A. P., . . . Dorling, J. (n.d.). Determining Optimal Outcome Measures in a Trial Investigating No Routine Gastric Residual Volume Measurement in Critically Ill Children. Journal of Parenteral and Enteral Nutrition. doi:10.1002/jpen.1817DOI: 10.1002/jpen.1817
Hewer, S. C. L., Smyth, A. R., Brown, M., Jones, A. P., Hickey, H., Kenna, D., . . . Williamson, P. R. (2021). Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and <i>Pseudomonas</i> <i>aeruginosa</i> infection: the TORPEDO-CF RCT. HEALTH TECHNOLOGY ASSESSMENT, 25(65), 1-+. doi:10.3310/hta25650DOI: 10.3310/hta25650
2020
Rosala-Hallas, A., Jones, A. P., Bedson, E., Compton, V., Fernandes, R. M., Lacy, D., . . . McNamara, P. S. (2020). National survey of feasibility of NIV trials for management of children with bronchiolitis.. BMJ Paediatrics Open, 4(1), e000780. doi:10.1136/bmjpo-2020-000780DOI: 10.1136/bmjpo-2020-000780
Hewer, S. C. L., Smyth, A. R., Brown, M., Jones, A. P., Hickey, H., Kenna, D., . . . Grp, T. O. R. P. E. D. O. -C. F. S. (2020). Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial. LANCET RESPIRATORY MEDICINE, 8(10), 975-986. doi:10.1016/S2213-2600(20)30331-3DOI: 10.1016/S2213-2600(20)30331-3
McKay, A. J., Jones, A. P., Gamble, C. L., Farmer, A. J., & Williamson, P. R. (2020). Use of routinely collected data in a UK cohort of publicly funded randomised clinical trials [version 1]. F1000Research, 9. doi:10.12688/f1000research.23316.1DOI: 10.12688/f1000research.23316.1
Tume, L. N., Woolfall, K., Arch, B., Roper, L., Deja, E., Jones, A. P., . . . Dorling, J. (2020). Routine gastric residual volume measurement to guide enteral feeding in mechanically ventilated infants and children: the GASTRIC feasibility study. HEALTH TECHNOLOGY ASSESSMENT, 24(23), 1-+. doi:10.3310/hta24230DOI: 10.3310/hta24230
McWilliam, S. J., Rosala-Hallas, A., Jones, A. P., Shaw, V., Greenhalf, W., Jaki, T., . . . Pirmohamed, M. (2020). A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis (vol 10, 1796, 2020). SCIENTIFIC REPORTS, 10(1). doi:10.1038/s41598-020-61783-9DOI: 10.1038/s41598-020-61783-9
Ramanan, A. V., Dick, A. D., Guly, C., McKay, A., Jones, A. P., Hardwick, B., . . . APTITUDE Trial Management Group. (2020). Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial. The Lancet Rheumatology, 2(3), e135-e141. doi:10.1016/s2665-9913(20)30008-4DOI: 10.1016/s2665-9913(20)30008-4
McWilliam, S. J., Rosala-Hallas, A., Jones, A. P., Shaw, V., Greenhalf, W., Jaki, T., . . . Pirmohamed, M. (2020). A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis.. Scientific reports, 10(1). doi:10.1038/s41598-020-58790-1DOI: 10.1038/s41598-020-58790-1
Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study. (Journal article)
Jones, A. P., Clayton, D., Nkhoma, G., Sherratt, F. C., Peak, M., Stones, S. R., . . . Baildam, E. M. (2020). Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study.. Health Technology Assessment, 24(36), 1-152. doi:10.3310/hta24360DOI: 10.3310/hta24360
2019
Horton, S., Jones, A. P., Guly, C. M., Hardwick, B., Beresford, M. W., Lee, R. W. J., . . . Ramanan, A. V. (2019). Adalimumab in juvenile-idiopathic arthritis-associated uveitis (JIA-U): 5-year follow-up of the Bristol participants of the SYCAMORE trial.. American journal of ophthalmology. doi:10.1016/j.ajo.2019.06.007DOI: 10.1016/j.ajo.2019.06.007
Ramanan, A. V., Hampson, L. V., Lythgoe, H., Jones, A. P., Hardwick, B., Hind, H., . . . Beresford, M. W. (2019). Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO. PLOS ONE, 14(6). doi:10.1371/journal.pone.0215739DOI: 10.1371/journal.pone.0215739
Ramanan, A. V., Dick, A. D., Jones, A. P., Hughes, D. A., McKay, A., Rosala-Halas, A., . . . Grp, S. Y. C. A. M. O. R. E. S. (2019). Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT. HEALTH TECHNOLOGY ASSESSMENT, 23(15), 1-139. doi:10.3310/hta23150DOI: 10.3310/hta23150
Hughes, D. A., Culeddu, G., Plumpton, C. O., Wood, E., Dick, A. D., Jones, A. P., . . . Ramanan, A. V. (2019). Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis. Ophthalmology, 126(3), 415-424. doi:10.1016/j.ophtha.2018.09.043DOI: 10.1016/j.ophtha.2018.09.043
2018
Irvine, A. D., Jones, A. P., Beattie, P., Baron, S., Browne, F., Ashoor, F., . . . Flohr, C. (2018). A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT). BRITISH JOURNAL OF DERMATOLOGY, 179(6), 1297-1306. doi:10.1111/bjd.16717DOI: 10.1111/bjd.16717
Interventions for helping people recognise early signs of recurrence in depression (Journal article)
Morriss, R. K., Bolton, C. A., McCarthy, J. P., Marshall, M., Williamson, P. R., & Jones, A. P. (n.d.). Interventions for helping people recognise early signs of recurrence in depression. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd004855.pub2DOI: 10.1002/14651858.cd004855.pub2
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial) (Journal article)
Ramanan, A. V., Dick, A. D., Jones, A. P., Guly, C., Hardwick, B., Hickey, H., . . . Beresford, M. W. (2018). A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial). BMC RHEUMATOLOGY, 2(1). doi:10.1186/s41927-018-0010-2DOI: 10.1186/s41927-018-0010-2
2017
Ramanan, A. V., Dick, A. D., Jones, A. P., McKay, A., Williamson, P. R., Compeyrot-Lacassagne, S., . . . Grp, S. Y. C. A. M. O. R. E. S. (2017). Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis. New England Journal of Medicine, 376(17), 1637-1646. doi:10.1056/NEJMoa1614160DOI: 10.1056/NEJMoa1614160
Nevitt, S. J., Jones, A. P., & Howard, J. (2017). Hydroxyurea (hydroxycarbamide) for sickle cell disease.. The Cochrane database of systematic reviews, 4, CD002202. doi:10.1002/14651858.cd002202.pub2DOI: 10.1002/14651858.cd002202.pub2
2016
Altowati, M. A., Jones, A. P., Hickey, H., Williamson, P. R., Barakat, F. M., Plaatjies, N. C., . . . Sanderson, I. R. (2016). Assessing the feasibility of injectable growth-promoting therapy in Crohn's disease.. Pilot and feasibility studies, 2, 71. doi:10.1186/s40814-016-0112-9DOI: 10.1186/s40814-016-0112-9
2014
Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit (Journal article)
Smith, C. T., Williamson, P., Jones, A., Smyth, A., Hewer, S. L., & Gamble, C. (2014). Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit. TRIALS, 15. doi:10.1186/1745-6215-15-127DOI: 10.1186/1745-6215-15-127
A Randomised Controlled Trial of the Clinical Effectiveness, Safety and Cost-Effectiveness of Adalimumab in Combination with Methotrexate for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis (Journal article)
Ramanan, A. V., Dick, A. D., McKay, A., Jones, A., Williamson, P., Compeyrot-Lacassagne, S., . . . Beresford, M. W. (2015). A Randomised Controlled Trial of the Clinical Effectiveness, Safety and Cost-Effectiveness of Adalimumab in Combination with Methotrexate for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis. ARTHRITIS & RHEUMATOLOGY, 67. Retrieved from https://www.webofscience.com/
A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial) (Journal article)
Ramanan, A. V., Dick, A. D., Benton, D., Compeyrot-Lacassagne, S., Dawoud, D., Hardwick, B., . . . The SYCAMORE Trial Management Group. (2014). A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial). Trials, 15. doi:10.1186/1745-6215-15-14DOI: 10.1186/1745-6215-15-14
Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit. (Journal article)
Tudur Smith, C., Williamson, P., Jones, A., Smyth, A., Hewer, S. L., & Gamble, C. (2014). Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit.. Trials, 16(15), 127.
2013
Jones, A. P., Conroy, E., Williamson, P. R., Clarke, M., & Gamble, C. (2013). The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials. BMC MEDICAL RESEARCH METHODOLOGY, 13. doi:10.1186/1471-2288-13-50DOI: 10.1186/1471-2288-13-50
The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials (Conference Paper)
Jones, A., Conroy, E., Williamson, P., Clarke, M., & Gamble, C. (2013). The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials. In Trials Vol. 14 (pp. O92). doi:10.1186/1745-6215-14-s1-o92DOI: 10.1186/1745-6215-14-s1-o92
The use of systematic reviews in the planning,design and condut of randomised trials (Performance)
Jones, A. P. (2013). The use of systematic reviews in the planning,design and condut of randomised trials [Public Performance].
2012
Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial (Journal article)
Gringras, P., Gamble, C., Jones, A. P., Wiggs, L., Williamson, P. R., Sutcliffe, A., . . . Appleton, R. (2012). Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial. BRITISH MEDICAL JOURNAL, 345. doi:10.1136/bmj.e6664DOI: 10.1136/bmj.e6664
Gringras, P., Gamble, C., Jones, A. P., Wiggs, L., Williamson, P. R., Sutcliffe, A., . . . Appleton, R. (2012). Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial. BMJ, 345(nov05 1), e6664. doi:10.1136/bmj.e6664DOI: 10.1136/bmj.e6664
The use of MElatonin in children with Neurodevelopmental Disorders and impaired Sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS) (Journal article)
Appleton, R. E., Jones, A. P., Gamble, C., Williamson, P. R., Wiggs, L., Montgomery, P., . . . Gringras, P. (2012). The use of MElatonin in children with Neurodevelopmental Disorders and impaired Sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS). HEALTH TECHNOLOGY ASSESSMENT, 16(40), 1-+. doi:10.3310/hta16400DOI: 10.3310/hta16400
The use of Melatonin in chidlren with Neurodevelopmental Disorders and impaired Sleep: a randomised double-blind, placebo-controlled, paralell study (MENDS) (Journal article)
Appleton, R. E., Jones, A. P., Gamble, C., Williamson, P. R., Wiggs, L., Montgomery, P., . . . Gringras, P. (2012). The use of Melatonin in chidlren with Neurodevelopmental Disorders and impaired Sleep: a randomised double-blind, placebo-controlled, paralell study (MENDS). HTA, 16(40).
2011
The use of the 5-year-olds' index: comparison between study models and intraoral photographs. (Journal article)
McAuliffe, N. J., Jones, A. P., Cumberbirch, V. C., & Russell, J. I. (2011). The use of the 5-year-olds' index: comparison between study models and intraoral photographs.. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association, 48(5), 526-531. doi:10.1597/09-265DOI: 10.1597/09-265
The use of Systematic reviews in the design of randomised controlled trials (Conference Paper)
Jones, A. P., Williamson, P. R., Clarke, M., & Gamble, C. (2011). The use of Systematic reviews in the design of randomised controlled trials. In MRC North West Hub for Trials Methodology Research 'Showcase Meeting' Vol. -. Liverpool: -.
The use of Systematic reviews in the design of randomised controlled trials (Conference Paper)
Jones, A. P., Williamson, P. R., Clarke, M., & Gamble, C. (2011). The use of Systematic reviews in the design of randomised controlled trials. In Clinical Trials Methodology conference Vol. -. -: MRC Network of HUBS for trials methodology Research.
The use of systematic reviews in the design of randomised trials (Performance)
Jones, A. P., Gamble, C., Clarke, M., & Williamson, P. R. (2011). The use of systematic reviews in the design of randomised trials [Undetermined].DOI: 10.1186/1745-6215-12-s1-a54
2010
Dornase alfa for cystic fibrosis. (Journal article)
Jones, A. P., & Wallis, C. (2010). Dornase alfa for cystic fibrosis.. The Cochrane database of systematic reviews, (3), CD001127. doi:10.1002/14651858.cd001127.pub2DOI: 10.1002/14651858.cd001127.pub2
Feasibility study to inform the design of a randomised controlled trial to eradicate <i>Pseudomonas aeruginosa</i> infection in individuals with Cystic Fibrosis (Journal article)
Hickey, H. R., Jones, A. P., Lenney, W., Williamson, P. R., & Smyth, R. L. (2010). Feasibility study to inform the design of a randomised controlled trial to eradicate <i>Pseudomonas aeruginosa</i> infection in individuals with Cystic Fibrosis. TRIALS, 11. doi:10.1186/1745-6215-11-11DOI: 10.1186/1745-6215-11-11
2009
Taylor-Robinson, D., Jones, A., & Garner, P. (2009). Does deworming improve growth and school performance in children?. PLoS neglected tropical diseases, 3(1), e358. doi:10.1371/journal.pntd.0000358DOI: 10.1371/journal.pntd.0000358
Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials (Journal article)
Jones, A. P., Riley, R. D., Williamson, P. R., & Whitehead, A. (2009). Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. CLINICAL TRIALS, 6(1), 16-27. doi:10.1177/1740774508100984DOI: 10.1177/1740774508100984
2008
Can Western developmental screening tools be modified for use in a rural Malawian setting? (Journal article)
Gladstone, M. J., Lancaster, G. A., Jones, A. P., Maleta, K., Mtitimila, E., Ashorn, P., & Smyth, R. L. (2008). Can Western developmental screening tools be modified for use in a rural Malawian setting?. ARCHIVES OF DISEASE IN CHILDHOOD, 93(1), 23-29. doi:10.1136/adc.2006.095471DOI: 10.1136/adc.2006.095471
2007
Taylor-Robinson, D. C., Jones, A. P., & Garner, P. (2007). Deworming drugs for treating soil-transmitted intestinal worms in children: effects on growth and school performance.. The Cochrane database of systematic reviews, (4), CD000371. doi:10.1002/14651858.cd000371.pub3DOI: 10.1002/14651858.cd000371.pub3
Non-invasive ventilation for cystic fibrosis. (Journal article)
Moran, F., Bradley, J. M., Jones, A. P., & Piper, A. J. (2007). Non-invasive ventilation for cystic fibrosis.. The Cochrane database of systematic reviews, (4), CD002769. doi:10.1002/14651858.cd002769.pub2DOI: 10.1002/14651858.cd002769.pub2
Interventions for helping people recognise early signs of recurrence in bipolar disorder (Journal article)
Morriss, R. K., Faizal, M. A., Jones, A. P., Williamson, P. R., Bolton, C., & McCarthy, J. P. (2007). Interventions for helping people recognise early signs of recurrence in bipolar disorder. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD004854.pub2DOI: 10.1002/14651858.CD004854.pub2
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation (Journal article)
McLeod, C., Bagust, A., Boland, A., Dagenais, P., Dickson, R., Dundar, Y., . . . Walley, T. (2007). Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. Unknown Journal, 1-158.
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. (Journal article)
McLeod, C., Bagust, A., Boland, A., Dagenais, P., Dickson, R., Dundar, Y., . . . Walley, T. (2007). Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.. Health technology assessment (Winchester, England), 11(28), 1-iv. doi:10.3310/hta11280DOI: 10.3310/hta11280
Deworming drugs for treating soil-transmitted intestinal worms in children: effects on growth and school performance (Journal article)
Taylor-Robinson, D. C., Jones, A. P., & Garner, P. (2007). Deworming drugs for treating soil-transmitted intestinal worms in children: effects on growth and school performance. Cochrane Database of Sytematic reviews, (1).
Training patients to recognise and manage early warning signs delays recurrence of bipolar disorder (Journal article)
Morriss, R. K., Faizal, M. A., Jones, A. P., Williamson, P. R., Bolton, C., & McCarthy, J. P. (2007). Training patients to recognise and manage early warning signs delays recurrence of bipolar disorder. Evidence-Based Mental Health, 10, 110.
2005
A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis (Journal article)
Carrol, E. D., Thomson, A. P. J., Jones, A. P., Jeffers, G., & Hart, C. A. (2005). A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis. INTENSIVE CARE MEDICINE, 31(10), 1415-1419. doi:10.1007/s00134-005-2787-xDOI: 10.1007/s00134-005-2787-x
High prevalence but low impact of data extraction and reporting errors were found in Cochrane systematic reviews (Journal article)
Jones, A. P., Remmington, T., Williamson, P. R., Ashby, D., & Smyth, R. L. (2005). High prevalence but low impact of data extraction and reporting errors were found in Cochrane systematic reviews. JOURNAL OF CLINICAL EPIDEMIOLOGY, 58(7), 741-742. doi:10.1016/j.jclinepi.2004.11.024DOI: 10.1016/j.jclinepi.2004.11.024
2003
Drug therapies for reducing gastric acidity in people with cystic fibrosis. (Journal article)
Ng, S. M., & Jones, A. P. (2003). Drug therapies for reducing gastric acidity in people with cystic fibrosis.. The Cochrane database of systematic reviews, (2), CD003424. doi:10.1002/14651858.cd003424DOI: 10.1002/14651858.cd003424
Recombinant human deoxyribonuclease for cystic fibrosis. (Journal article)
Jones, A. P., & Wallis, C. E. (2003). Recombinant human deoxyribonuclease for cystic fibrosis.. The Cochrane database of systematic reviews, (3), CD001127. doi:10.1002/14651858.cd001127DOI: 10.1002/14651858.cd001127